Management of Persistent GERD Symptoms After OTC PPI Trial

Assessment and Diagnosis

The American Gastroenterological Association recommends that patients with typical GERD symptoms that have shown minimal response to 2 months of over-the-counter PPI therapy should undergo an upper endoscopy with possible prolonged wireless pH monitoring to evaluate the cause of PPI-refractory symptoms 1, 2
Patients over 50 years of age with a significant smoking history are at increased risk for more serious pathology, including Barrett's esophagus, and should undergo upper endoscopy 1, 3
The presence of obesity (BMI 32) is a risk factor for GERD and should be considered in the assessment of patients with persistent symptoms 1, 2
The absence of alarm symptoms such as dysphagia, weight loss, or anemia is reassuring, but does not rule out the need for further evaluation 2

Upper endoscopy is indicated as the next step for patients with inadequate response to a PPI trial, as it allows for assessment of erosive esophagitis, Barrett's esophagus, and other structural causes 1, 2, 4
Complete endoscopic evaluation should include inspection for erosive esophagitis, assessment of diaphragmatic hiatus and hiatal hernia, and evaluation for Barrett's esophagus 3, 4, 5
If endoscopy shows Los Angeles grade B or higher esophagitis or long-segment Barrett's esophagus, diagnosis of GERD is confirmed, and treatment should be optimized with prescription-strength PPI 1
If endoscopy shows normal findings or LA grade A esophagitis, prolonged wireless pH monitoring off PPI therapy should be performed to confirm and phenotype GERD 1, 2

The American College of Gastroenterology recommends that patients with confirmed GERD should be treated with prescription-strength PPI at optimal dosing, and consider twice-daily dosing or switching to a more effective acid suppressive agent 3, 6
Personalized adjunctive therapy based on symptom pattern, such as H2 blockers for nocturnal symptoms or alginate antacids for breakthrough symptoms, may be beneficial 7
Lifestyle modifications, including weight management, dietary modifications, and elevation of the head of the bed, should be emphasized regardless of diagnostic findings 6

Verify PPI usage patterns before proceeding to invasive testing, and confirm that the patient has been taking the PPI correctly 3
Avoid empiric dose escalation without diagnostic confirmation, and establish a definitive diagnosis through endoscopy and possibly pH monitoring 1
Long-term PPI therapy should be approached with caution, and patients should be counseled about potential risks, including vitamin B12 deficiency, hypomagnesemia, and increased risk of fractures 8